share_log

大成生化科技(00809)发盈喜 预计年度取得净溢利36亿港元至40亿港元 同比扭亏为盈

Dacheng Biochemical Technology (00809) is expected to achieve annual net profit of HK$3.6 billion to HK$4 billion, turning a year-on-year loss into profit

Zhitong Finance ·  Feb 29 05:17

Dacheng Biochemical Technology (00809) issued an announcement. Regarding the Group's continued operation and discontinued business, the Group expects to...

According to the Zhitong Finance App, Dacheng Biochemical Technology (00809) issued an announcement. Regarding the Group's continued operation and discontinued operations, the Group expects to achieve net profit (excluding tax effects) for the year ended 31 December 2023. The range is about HK$3.6 billion to HK$4 billion. Compared with the year ended 31 December 2022, the net loss (excluding tax impact) was approximately HK$1,574 billion. The Group's terminated business means that Dacheng Sugar Holdings Limited (“Dacheng Sugar”, together with its subsidiaries, collectively, “Dacheng Sugar Group”) (a company listed on the main board of the Stock Exchange, stock code: 03889) and its subsidiaries, ceased to be part of the Group after the Group completed the sale of Dacheng Sugar Group on December 21, 2023.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment